ABSTRACT
I. Introduction With more than 400 specific drugs capable of injuring the respiratory system, druginduced respiratory disease has become an important etiologic consideration in patients with interstitial lung disease (ILD), pulmonary edema, upper airway obstruction, and acute bronchospasm (1). Patients with drug-induced respiratory complications may present acutely with the sudden onset of cardiopulmonary failure or asphyxia, requiring prompt recognition and identification of the causal drug along with emergent management to secure the airway and/or to restore gas exchange (2).
